Article
Low Expression of Iron–Sulfur Cluster Binding Protein RFESD Predicts Adverse Clinic Outcomes in Acute Myeloid Leukemia
2026-07-05
Abstract excerpt
<title>Abstract</title> <p>Acute myeloid leukemia (AML) is a devastating hematopoietic malignancy with high heterogeneity and poor outcomes. In this study, we searched for the new biomarker to promote the efficacy of diagnosis, therapy and prognosis of AML by transcriptome and clinical information from the Cancer Genome Atlas (TCGA) database, Gene Expression Omnibus (GEO) datasets, and Genotype-Tissue Expression...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0da77f18-18af-5aec-a199-7c8d15d74d11
- DOI
- 10.21203/rs.3.rs-10224596/v1
